Healthcare

Ipsos is currently running syndicated COVID-19 impact studies to uncover the true impact of the pandemic in key disease areas. Studies gather the perspectives of treating doctors and patients on key issues such as treatment decision-making, patient management, the patient experience and more.

Read our five recommendations for medical device manufacturers to maintain connections and foster effective engagement with customers during Covid-19.

Read our white paper to review key considerations for medical device companies to redefine risk, identify opportunities and adapt during Covid-19.

COVID-19 overtakes all other issues in Ipsos’ What Worries the World survey with the highest level of concern recorded for any category since the series began.

As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.

Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.

Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.

The world of pharma business insight is likely to change as it embraces a multi-data source reality.

What are the treatment options for this too-prevalent disease? And the outlook for the future as clinical outcomes evolve?